L P Jalar
Overview
Explore the profile of L P Jalar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
35
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ekstrom B, Jalar L, Magni L
Infection
. 1979 Jan;
7 Suppl 5:S438-42.
PMID: 389821
Bacampicillin is an orally well-absorbed pro-drug of ampicillin giving high in vivo levels of the latter. Its therapeutic activity was compared with that of amoxycillin in two experimental infection models...
2.
FORSGREN U, Ekstrom B, Jalar L, Magni L
Scand J Infect Dis Suppl
. 1978 Jan;
(14):207-13.
PMID: 279973
The therapeutic activity of bacampicillin compared to that of ampicillin and amoxycillin was evaluated against experimental infections in mice. Median curative doses (CD50) were determined in groups of animals challenged...
3.
BODIN N, Ekstrom B, FORSGREN U, Jalar L, Magni L, Ramsay C, et al.
Antimicrob Agents Chemother
. 1975 Nov;
8(5):518-25.
PMID: 1211909
Bacampicillin (proposed international nonproprietary name), 1'-ethoxycarbonyloxyethyl 6-(d-alpha-aminophenylacetamido)penicillanate, is a new orally well-absorbed penicillin, highly active in vivo due to rapid transformation into ampicillin. The compound is stable in vitro at...